WuXi PharmaTech (Cayman) Inc. Restricted Stock or Unit Expense
WuXi PharmaTech (Cayman) Inc. reported Restricted Stock or Unit Expense of $22.88 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2015-04-15
| Period end | Restricted Stock or Unit Expense 12 month | Restricted Stock or Unit Expense 12 month as first filed |
|---|---|---|
| 2014-12-31 | $22.88M 20-F · filed 2015-04-15 | |
| 2013-12-31 | $17.64M 20-F · filed 2015-04-15 | $17.62M 20-F · filed 2014-04-15 |
| 2012-12-31 | $13.83M 20-F · filed 2015-04-15 | |
| 2011-12-31 | $11.37M 20-F · filed 2014-04-15 | |
| 2010-12-31 | $8.85M 20-F · filed 2013-04-17 | |
| 2009-12-31 | $7.29M 20-F · filed 2012-04-20 |